share_log

モダリス---大幅続伸、米バイオプロセスサミットでの発表に期待が集まる

Modaris - Significant increase, expectations are high for announcements at the US Bioprocess Summit.

Fisco Japan ·  Jul 30 00:20


Marked increase. The disclosure that it will announce the muscle-specific modified AAV vector manufacturing development data of MDL-101 at the 16th BioProcess Summit held in Boston, USA from August 19th to 22nd continues to be regarded as a material. Although research on the modified capsid is progressing rapidly in many groups and achieving remarkable results, manufacturing for practical use is still in the developmental stage. At this conference, the company will present information including the production method and results of MDL-101, which is undergoing clinical development using muscle-specific modified AAV vectors.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment